Minimal Residual Disease in Acute Lymphoblastic Leukemia
1 意见
• 06/15/23
0
0
嵌入
The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论